Neoplasia/BPH

	Routine Retrograde Conduitography after Radical Cystectomy for Bladder Cancer: Diagnostic Yield and Clinical Impact. Urol Int Scheper V, Berninger L, Schwinger M, Woidich R, Egenolf T, Däuwel M, Hahn O, Seitz AK, Kübler H, Kalogirou C. PMID: 42048277 [PubMed - as supplied by publisher]
	Metformin in prostate cancer: a context-dependent antitumour strategy driven by metabolic vulnerability and signalling network. Discov Oncol Yan L, Chen D, Wu T, Zhao J, Xu X, Xu W, Zhang H, Xiao M. PMID: 42047898 [PubMed - as supplied by publisher]
	Active surveillance for renal masses up to 2Â cm: long-term oncological outcomes from a prospective multi-institutional study. World J Urol Re C, Bertini A, Scilipoti P, Saccucci T, Mantica G, Cazzaniga W, Matloob R, Conti G, Maccagnano C, Furlan M, Suardi N, Simeone C, Montanari E, Albo G, Stagni S, Salvioni R, Castiglione F, Larcher A, Rosiello G, Terrone C, Montorsi F, Salonia A, Capitanio U, Bertini R. PMID: 42047824 [PubMed - indexed for MEDLINE]
	Prostate cancer cells' growth is decreased by novel MYC inhibitors. Invest New Drugs Nickkholgh B, McGrath J, Sittadjody S, Chauhan J, Fletcher S, Balaji KC. PMID: 42047739 [PubMed - as supplied by publisher]
	Rewired lipid metabolism in castration-resistant prostate cancer: molecular interplay between glucose metabolism and sterol synthesis. Mol Biol Rep K B HP, Arockiasamy S, Krishnamoorthy S. PMID: 42047726 [PubMed - in process]
	Comment on: "Comparison of long-term survival for muscle-invasive bladder cancer patients who underwent bladder preservation therapy and radical cystectomy: A systematic review and meta-analysis". Urologia Sacco E, Bizzarri FP. PMID: 42047691 [PubMed - as supplied by publisher]
	Gleason Regrading After Prostatectomy-Results From the Irish Prostate Cancer Outcome Research (IPCOR) Situated in the International Context. Int J Urol Gordon N, Patel AA, Farooq W, Watson W, Galvin D. PMID: 42047450 [PubMed - indexed for MEDLINE]
	Awareness and Knowledge of Penile Cancer Among University Students in Ghana. Am J Mens Health Avinu ES, Yeboah RNY, Bediako Agyei F, Petershie BE. PMID: 42047328 [PubMed - indexed for MEDLINE]
	Urine-Based Noninvasive Detection of Prostate Cancer Using Human Olfactory Receptor-Embedded Nanodiscs. ACS Sens Yoo J, Kim Y, Kang K, Ahn YJ, Bang S, Koo KC, Park TH. PMID: 42047253 [PubMed - as supplied by publisher]
	18F choline PET/MR to assess clinically significant disease in prostate cancer: correlation with maximum and total cancer core length obtained via template mapping biopsies. Nucl Med Commun Haroon A, Almuhaideb A, Adeleke S, Davis LM, Endozo R, Allie R, Afaq A, Syed GMS, Ghafoor S, Emberton M, Bomanji J. PMID: 42046529 [PubMed - as supplied by publisher]
	Predicting the upgrading of the International Society of Urological Pathology Grade Group in nonclinically significant prostate cancer: a multicenter observational study. Asian J Androl Zhou L, Li SY, Wang ZY, Liu YY, Chen C, Yu H. PMID: 42046346 [PubMed - as supplied by publisher]
	Urinary Peptidomic Signatures Predict Overall and Progression-Free Survival in Bladder Cancer. Proteomics Ahangar M, Mischak H, Moulavasilis N, Stravodimos K, Mahjoubi F, Jankowski J, Frantzi M, Vlahou A. PMID: 42046269 [PubMed - as supplied by publisher]
	Evaluation of prostate cancer diagnosis during the COVID-19 crisis in the French Caribbean. Sci Rep Beaubrun-Renard M, Ulric-Gervaise S, Macni J, Puello A, Cabie A, Joachim C. PMID: 42045399 [PubMed - as supplied by publisher]
	Self-Assembled DNA Nanoladder-Based Electrochemical Biosensor for Rapid and Sensitive Detection of Bladder Tumor-Related miRNA in Urine. Anal Chem Wang J, Liu J, Wang Y, Yan W, Sun H, Liu S, Tan Y, Huang J. PMID: 42045126 [PubMed - as supplied by publisher]
	The LDR BURST trial: a randomised controlled trial comparing the side effects of low-dose-rate brachytherapy against ultra-hypofractionated radiotherapy using spacer gel treatment in men with Cambridge Prognostic Groups 1-3 prostate cancer. BMJ Open Hayhurst W, Uribe-Lewis S, Uribe J, Mikropoulos C, Otter S, Goh C, Mehta S, Wood K, Deering C, Higgins D, Langley S, Long M, Michael A, Langley S, Perna C. PMID: 42044963 [PubMed - indexed for MEDLINE]
	Important Role of Ultrasound in Assessing Tubulocystic Renal Cell Carcinoma. Ultrasound Q Choi R, Radzinsky E, Morgan T, Fananapazir G. PMID: 42044518 [PubMed - indexed for MEDLINE]
	Life expectancy estimation in older men using the prostate cancer comorbidity index in VA & SEER-Medicare cohorts. Age Ageing Heard J, Luu M, Thomas IC, Leppert J, Daskivich T. PMID: 42043951 [PubMed - indexed for MEDLINE]
	Mechanism of Qianlong Shutong Formula in the Treatment of Benign Prostatic Hyperplasia by Regulating Metabolism and Protein Function. Biomed Chromatogr Zhang ZC, Ye XJ, Shang CJ, Chen Y, Guo L, Li YW, Zhu M, Tang BT, Liang TS. PMID: 42043779 [PubMed - indexed for MEDLINE]
	Correction: UCHL5 is a putative prognostic marker in renal cell carcinoma: a study of UCHL family. Mol Biomed Zhang M, Li J, Liu S, Zhou F, Zhang L. PMID: 42043492 [PubMed - in process]
	Classifying Kidney Tumor via Adaptive SE-ResNeXt With Mutli-Novel Loss Function and Renal Mass Segmentation Using Pyramidal Attention-Based R2Unet++ Model. J Biochem Mol Toxicol Jayasingh BB, Infantia HN, Panse T. PMID: 42043283 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 187384

Page 1 of 9370



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy